Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
227.86
-0.04 (-0.02%)
Jul 24, 2026, 4:00 PM EDT - Market closed

Quest Diagnostics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
1,1131,0469219081,0152,080
Depreciation & Amortization
727570493439437408
Stock-Based Compensation
888888777779
Other Adjustments
15913233-770-421
Change in Receivables
-250-106-71-1524681
Changes in Accounts Payable
270129-67-55-14935
Changes in Income Taxes Payable
192416-2-31-20
Changes in Other Operating Activities
-763-79-7353-9
Operating Cash Flow
1,9031,8861,3341,2721,7182,233
Operating Cash Flow Growth
13.41%41.38%4.87%-25.96%-23.06%11.37%
Capital Expenditures
-554-527-425-408-404-403
Cash Acquisitions
-122-101-2,164-611-144-331
Proceeds from Business Divestments
-----755
Other Investing Activities
-2-341-425-
Investing Cash Flow
-678-631-2,548-1,061-54321
Long-Term Debt Issued
5044101,8462,592--
Long-Term Debt Repaid
-512-1,012-303-1,844-2-2
Net Long-Term Debt Issued (Repaid)
-8-6021,543748-2-2
Issuance of Common Stock
118797372123129
Repurchase of Common Stock
-450-450-151-275-1,408-2,199
Net Common Stock Issued (Repurchased)
-332-371-78-203-1,285-2,070
Common Dividends Paid
-363-353-331-314-305-309
Other Financing Activities
-110-62-50-71-140-159
Financing Cash Flow
-915-1,3881,084160-1,732-2,540
Effect of Exchange Rate Changes on Cash and Cash Equivalents
-34-7---
Net Cash Flow
307-129-137371-557-286
Free Cash Flow
1,3491,3599098641,3141,830
Free Cash Flow Growth
10.21%49.50%5.21%-34.25%-28.20%15.31%
FCF Margin
11.67%12.32%9.21%9.34%13.30%16.96%
Free Cash Flow Per Share
12.0212.038.047.6511.1414.30
Levered Free Cash Flow
1,4405892,3521,5038502,004
Unlevered Free Cash Flow
1,6521,396976.25892.261,0391,861
SEC Filings: 10-K · 10-Q